Heart Failure Department

The Heart Failure Department is responsible for inpatient treatment of heart-failure and LVAD patients, post-discharge follow-up, VAD-related clinical trials, and management of the VAD Center of Taixin Hospital. Clinical research includes a multicenter, randomized, double-blind, placebo-controlled, dose-escalation phase I study evaluating BC003 safety, tolerability, pharmacokinetics, and preliminary efficacy in acute decompensated heart failure (ADHF) patients with dyspnea at rest or during mild activity; a post-marketing clinical study collecting data on an implantable left ventricular assist system; and design and development of VAD-patient follow-up software.